References: Blair E, Miller A
While these results do not prove that GLP-1 drugs prevent colorectal cancer, they do help clarify whether GLP-1 drugs could be a future option for lowering colorectal cancer risk
At week 72, the clinical data showed that 36.8% of patients receiving semaglutide achieved fibrosis improvement without worsening of NASH and 62.9% achieved NASH resolution without worsening of fibrosis, compared with 22.4% and 34.3%, respectively, in the placebo group (Sanyal et al., 2025)
Formulated with a comprehensive selection of essential vitamins and nutrients, each gummy includes Vitamins C, D, E, B6, B12, riboflavin, folate (L-methylfolate calcium), biotin, zinc (as zinc citrate), pantothenic acid (as calcium D-pantothenate), and omega-3 fatty acids from chia seed extract
255 A randomized controlled trial in 320 NASH patients found 59% of those who received 72 weeks of treatment with subcutaneous injections of the GLP-1 RA semaglutide (Ozempic or Wegovy) and 17% of those receiving placebo experienced resolution of biopsy-confirmed NASH, although changes in fibrosis were not significantly different between groups
.webp)
